Mechanical effects of ET-1 in cardiomyocytes isolated from normal and heart-failed rabbits

Molecular and Cellular Biochemistry

Volumn 157, Issue 1-2, 1996, Pages 149-155

  Kelso, Elizabeth J ^a   Geraghty, Robert F ^a   McDermott, Barbara J ^a   Trimble, Elisabeth R ^a   Nicholls, D Paul ^b   Silke, Bernard ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

Calcium; Contraction; Endothelin 1; Heart failure; Ventricular cardiomyocytes

Indexed keywords

COLLAGENASE; ENDOTHELIN 1; ENDOTHELIN RECEPTOR; EPIRUBICIN; INOTROPIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CALCIUM CELL LEVEL; CALCIUM CONDUCTANCE; CALCIUM CURRENT; CARDIOMYOPATHY; CONCENTRATION RESPONSE; CONTROLLED STUDY; HEART CONTRACTION; HEART FAILURE; HEART MUSCLE CELL; MALE; MEMBRANE CONDUCTANCE; MICROSCOPY; MUSCLE FIBER CONTRACTION; NONHUMAN; PATCH CLAMP; PROTEIN BLOOD LEVEL; RABBIT; SIGNAL TRANSDUCTION;

EID: 0029971708     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00227893     Document Type: Article

References (29)

1. Creager MA, Faxon DP, Cutler SS, Kohlman 0, Ryan TJ, Gavras H: Contribution of vasopressin to vasoconstriction in patients with congestive heart failure: comparison with renin-angiotensin system and the sympathetic nervous system. J Am Coll cardiol 7: 758-765, 1986
2. Packer M: Pathophysiology of chronic heart failure. Lancet, July: 88-95
3. Kiuchi K, Sato N, Shannon RP, Vatner DE, Morgan K, Vatner SF. Depressed β-adrenergic receptor- and endothelium-mediated vasodilation in conscious dogs with heart failure. Circ Res 73: 1013-1023, 1993
4. Elkayam U, Amin J, Mehra A, Vasquez J, Weber L, Rahimtoola SH: A prospective, randomized, double-blind, cross-over study to compare the efficacy and safety of chronic nifedipine therapy to isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure. Circ 82: 1954-1961, 1990
5. Margulies KB, Hildebrand FL, Lerman A, Perella MA, Burnett JC. Increased endothelin in experimental heart failure. Circ 82: 2226-2230, 1990
6. Rubanyi GM, Polokoff MA: Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 46: 325-415, 1994
7. Miyauchi T, Yanagisawa M, Tomizawa T, Sugishita Y, Suzuki N, Fujino M, Ajisaka R, Goto K, Masaki T. Increased plasma concentrations of endothelin-1 and big endothelin-1 in acute myocardial infarction. Lancet 2: 53-54, 1989
8. Kusumoto K, Awane Y, Fujiwara S, Watanabe T: Role of endogenous endothelin in extension of rabbit myocardial infarction. J Cardiovasc Pharmacol 22: S339-S342, 1993
9. Watanabe T, Suzuki N, Shimamoto N, Fujino M, Imada A: Contribution of endogenous endothelin to the extension of myocardial infarct size in rats. Circ Res 69: 370-377, 1991
10. Grover GJ, Dzwonczyk S, Parham CS: The endothelin-1 receptor antagonist BQ-123 reduces infarct size in a canine model of coronary occlusion and reperfusion. Cardiovasc Res 27: 1613-1618, 1993
11. Kelly RA, Hoda E, Kramer BK, O'Neill M, Liang BT, Reers M, Smith TW: Endothelin enhances the contractile responsiveness of adult rat ventricular myocytes to calcium by a pertussis toxin-sensitive pathway. J Clin Invest 86: 1164-1171, 1990
12. Arnolda L, McGrath B, Cocks M, Sumithran E, Johnston C: Adriamycin cardiomyopathy in the rabbit: an animal model of low output cardiac failure with activation of vasoconstrictor mechanisms. Cardiovasc Res 19: 378-382, 1985
13. Geraghty RF, Kelso EJ, McDermott BJ, Trimble ER, Nicholls DP: Characterization of ventricular cardiomyocytes isolated fromm rabbits with epirubicin-induced heart failure. Br J Pharmacol, 1995
14. Kelso EJ, McDermott BJ, Silke B: Actions of the novel vasodilator, flosequinan, in isolated venricular cardiomyocytes. J Cardiovasc Pharmacol 25: 376-386, 1995
15. 2+ current from rabbit ventricular cardiomyocytes. J MoI Cell Cardiol, in press, 1995
16. Endoh M, Takanashi M: Inotropic effects of endothelin on mammalian ventricular contractility. Basic Res Cardiol 86: 173-178, 1991
17. Moravec CS, Reynolds EE, Stewart RW, Bond M: Endothelin is a positive inotropic agent in human and rat heart in vitro. Biochem Biophys Res Commun 159: 14-18, 1989
18. Takanashi M, Endoh M: Characterisation of positive inotropic effect of endothelin on mammalian ventricular myocardium. Am J Physiol 261: H611-H619, 1991
19. A receptor antagonist. J Cardiovasc Res 24: 587-594, 1994
20. + exchanger. Circ Res 68: 269-279, 1991
21. Ishikawa K, Yanagisawa M, Kimura S, Goto K, Masaki T: Positive inotropic action of novel vasoconstrictor peptide endothelin on guinea-pig atria. Am J Physiol 255: H970-H973, 1988
22. Shah AM, Lewis MJ, Henderson AH: Inotropic effects of endothelin in ferret ventricular myocardium. Eur J Pharmacol 163: 365-367, 1989
23. Takanashi M, Endoh M: Concentration- and time-dependence of phosphoinositide hydrolysis induced by endothelin-1 in relation to the positive inotropic effect in the rabbit ventricular myocardium. J Pharmacol Exp Thera 262: 1189-1194, 1992
24. A-receptors couple to inositol phosphate formationand inhibition of adenylate cyclase in right atrium. J Cardiovasc Pharmacol 23: 344-347, 1994
25. Huggins JP, Pelton JT, Miller RC: The Structure and specificity of endothelin receptors: their importance in physiology and medicine. Pharmac Ther 59, 55-123, 1993
26. Buxton ILO, Brunton LL: Beta-adrenergic receptor subtypes and subcellular compartmentation of cyclic AMP and cyclic AMP-dependent protein kinase in rabbit cardiomyocytes. Biochem Int 11: 137-144, 1985
27. Jones SM, Kirby MS, Harding SE, Vescova G, Wanless RB, Libera LD, Poole-Wilson PA: Adriamycin cardiomyopathy in the rabbit: alterations in contractile proteins and myocyte function. Cardiovasc Res 24: 834-842, 1990
28. Harden TK: Agonist-induced desensitization of the -adrenergic receptor-linked adenylate cyclase. Pharmacol Rev 35: 5-31, 1983
29. Harding SE, Jones SM, O'Gara P, del Monte F, Vescovo G, Poole-Wilson PA: Isolated ventricular cardiomyocytes from failing and nonfailing human heart; the relation of age and clinical status of patients to isoproterenol response. J Mol Cell Cardiol 24: 549-564, 1992